Nalaganje...

Cancer immunotherapies targeting the PD-1 signaling pathway

Immunotherapy has recently emerged as the fourth pillar of cancer treatment, joining surgery, radiation, and chemotherapy. While early immunotherapies focused on accelerating T-cell activity, current immune-checkpoint inhibitors take the brakes off the anti-tumor immune responses. Successful clinica...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Biomed Sci
Main Authors: Iwai, Yoshiko, Hamanishi, Junzo, Chamoto, Kenji, Honjo, Tasuku
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5381059/
https://ncbi.nlm.nih.gov/pubmed/28376884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-017-0329-9
Oznake: Označite
Brez oznak, prvi označite!